Mitsubishi UFJ Asset Management’s 10x Genomics TXG Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.75K	Hold	124	–	–	﹤0.01%	1557
2026 Q1	$2.63K	Hold	124	–	–	﹤0.01%	1575
2025 Q4	$2.06K	Hold	124	–	–	﹤0.01%	1595
2025 Q3	$1.45K	Hold	124	–	–	﹤0.01%	1593
2025 Q2	$1.44K	Hold	124	–	–	﹤0.01%	1601
2025 Q1	$1.08K	Hold	124	–	–	﹤0.01%	1592
2024 Q4	$1.93K	Hold	124	–	–	﹤0.01%	1577
2024 Q3	$2.8K	Hold	124	–	–	﹤0.01%	1547
2024 Q2	$2.41K	Hold	124	–	–	﹤0.01%	1543
2024 Q1	$4.65K	Hold	124	–	–	﹤0.01%	1352
2023 Q4	$6.32K	Hold	124	–	–	﹤0.01%	1240
2023 Q3	$5.12K	Buy	+124	New	+$6.45K	﹤0.01%	1262
2022 Q2	–	Sell	-17,941	Closed	-$1.36M	–	1205
2022 Q1	$1.36M	Sell	17,941 -476	-3%	-$41.6K	0.01%	797
2021 Q4	$2.69M	Buy	18,417 +941	+5%	+$144K	0.01%	697
2021 Q3	$2.54M	Buy	17,476 +2,021	+13%	+$347K	0.01%	700
2021 Q2	$3.03M	Buy	15,455 +1,608	+12%	+$291K	0.02%	665
2021 Q1	$2.51M	Buy	13,847 +2,238	+19%	+$386K	0.02%	652
2020 Q4	$1.64M	Buy	+11,609	New	+$1.68M	0.01%	688

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mitsubishi UFJ Asset Management's TXG Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its 10x Genomics (TXG) position steady in Q2 2026 at 124 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.

Mitsubishi UFJ Asset Management first reported a position in TXG in Q4 2020 and has held it in 18 quarters since. The position peaked at $3.03M in Q2 2021. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Mitsubishi UFJ Asset Management held 124 shares of 10x Genomics worth $4.75K as of Q2 2026.
Mitsubishi UFJ Asset Management left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1557 holding.
Mitsubishi UFJ Asset Management first reported a position in 10x Genomics in Q4 2020 and has held it in 18 quarters since.
Mitsubishi UFJ Asset Management's 10x Genomics position peaked at $3.03M in Q2 2021.
393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.